SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-030705
Filing Date
2023-05-18
Accepted
2023-05-18 17:13:49
Documents
1
Period of Report
2023-05-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1559
  Complete submission text file 0001209191-23-030705.txt   3273
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Issuer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1120 S CAPITAL OF TX HWY BLDG 1, STE 300 AUSTIN TX 78746
Business Address
Cavanaugh Stefanie L. (Reporting) CIK: 0001688530 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34810 | Film No.: 23937095